Fig. 8.
DFSs of patients with advanced disease; 48 patients received cyclosporine/methotrexate, 30.8% (◊) and 68 patients received tacrolimus/methotrexate, 20.4% (□); absolute difference = 10.4%, 95% CI = −26.7 to 6.0 (P = .007, Wilcoxon).
DFSs of patients with advanced disease; 48 patients received cyclosporine/methotrexate, 30.8% (◊) and 68 patients received tacrolimus/methotrexate, 20.4% (□); absolute difference = 10.4%, 95% CI = −26.7 to 6.0 (P = .007, Wilcoxon).
